These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 16753830
1. Colon-specific delivery and enhanced colonic absorption of [Asu(1,7)]-eel calcitonin using chitosan capsules containing various additives in rats. Fetih G, Fausia H, Okada N, Fujita T, Attia M, Yamamoto A. J Drug Target; 2006 Apr; 14(3):165-72. PubMed ID: 16753830 [Abstract] [Full Text] [Related]
2. Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats. Morita T, Yamamoto A, Takakura Y, Hashida M, Sezaki H. Pharm Res; 1994 Jun; 11(6):909-13. PubMed ID: 7937534 [Abstract] [Full Text] [Related]
3. Enhanced absorption of insulin and (Asu(1,7))eel-calcitonin using novel azopolymer-coated pellets for colon-specific drug delivery. Tozaki H, Nishioka J, Komoike J, Okada N, Fujita T, Muranishi S, Kim SI, Terashima H, Yamamoto A. J Pharm Sci; 2001 Jan; 90(1):89-97. PubMed ID: 11064382 [Abstract] [Full Text] [Related]
4. Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. Tozaki H, Komoike J, Tada C, Maruyama T, Terabe A, Suzuki T, Yamamoto A, Muranishi S. J Pharm Sci; 1997 Sep; 86(9):1016-21. PubMed ID: 9294815 [Abstract] [Full Text] [Related]
7. Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu(1,7)]-eel calcitonin in rats. Fetih G, Habib F, Okada N, Fujita T, Attia M, Yamamoto A. J Control Release; 2005 Sep 02; 106(3):287-97. PubMed ID: 15982776 [Abstract] [Full Text] [Related]
8. Studies of drug delivery systems for a therapeutic agent used in osteoporosis. I. Pharmacodynamics (hypocalcemic effect) of elcatonin in rabbits following rectal administration of hollow-type suppositories containing elcatonin. Watanabe Y, Mizufune Y, Kubomura A, Kiriyama M, Utoguchi N, Matsumoto M. Biol Pharm Bull; 1998 Nov 02; 21(11):1187-90. PubMed ID: 9853410 [Abstract] [Full Text] [Related]
9. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules. Fetih G, Lindberg S, Itoh K, Okada N, Fujita T, Habib F, Artersson P, Attia M, Yamamoto A. Int J Pharm; 2005 Apr 11; 293(1-2):127-35. PubMed ID: 15778050 [Abstract] [Full Text] [Related]
10. Absorption-improving effects of chitosan oligomers based on their mucoadhesive properties: a comparative study on the oral and pulmonary delivery of calcitonin. Zhang H, Huang X, Sun Y, Xing J, Yamamoto A, Gao Y. Drug Deliv; 2016 Sep 11; 23(7):2419-2427. PubMed ID: 25594571 [Abstract] [Full Text] [Related]
11. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. Tozaki H, Odoriba T, Okada N, Fujita T, Terabe A, Suzuki T, Okabe S, Muranishi S, Yamamoto A. J Control Release; 2002 Jul 18; 82(1):51-61. PubMed ID: 12106976 [Abstract] [Full Text] [Related]
12. Studies of drug delivery systems for a therapeutic agent used in osteoporosis. II. Enhanced absorption of elcatonin from nasal mucosa in rabbits. Watanabe Y, Mizufune Y, Utoguchi N, Endo K, Matsumoto M. Biol Pharm Bull; 1998 Nov 18; 21(11):1191-4. PubMed ID: 9853411 [Abstract] [Full Text] [Related]
13. Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier. Huang BB, Li GF, Luo JH, Duan L, Nobuaki K, Akira Y. World J Gastroenterol; 2008 Aug 21; 14(31):4928-37. PubMed ID: 18756602 [Abstract] [Full Text] [Related]
14. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride. du Plessis LH, Lubbe J, Strauss T, Kotzé AF. Int J Pharm; 2010 Jan 29; 385(1-2):181-6. PubMed ID: 19854253 [Abstract] [Full Text] [Related]
15. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Takeuchi H, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. Int J Pharm; 2005 Oct 13; 303(1-2):160-70. PubMed ID: 16125348 [Abstract] [Full Text] [Related]
16. Oral delivery of synthetic eel calcitonin, elcatonin, in rats. Ogiso T, Funahashi N, Tsukioka Y, Iwaki M, Tanino T, Wada T. Biol Pharm Bull; 2001 Jun 13; 24(6):656-61. PubMed ID: 11411554 [Abstract] [Full Text] [Related]
17. Absorption of water-soluble compounds with different molecular weights and. Yamamoto A, Iseki T, Ochi-Sugiyama M, Okada N, Fujita T, Muranishi S. J Control Release; 2001 Oct 19; 76(3):363-74. PubMed ID: 11578749 [Abstract] [Full Text] [Related]
18. Use of protease inhibitors to improve calcitonin absorption from the small and large intestine in rats. Tozaki H, Odoriba T, Iseki T, Taniguchi T, Fujita T, Murakami M, Muranishi S, Yamamoto A. J Pharm Pharmacol; 1998 Aug 19; 50(8):913-20. PubMed ID: 9751457 [Abstract] [Full Text] [Related]
19. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers. Huang A, Su Z, Li S, Sun M, Xiao Y, Ping Q, Deng Y. Drug Deliv; 2014 Aug 19; 21(5):388-96. PubMed ID: 24188463 [Abstract] [Full Text] [Related]
20. Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats. Wu L, Zhang G, Lu Q, Sun Q, Wang M, Li N, Gao Z, Sun Y, Li T, Han D, Yu X, Wang L, Sun W, Zhao D, Wu Y, Lu Y, Chen X. Drug Dev Ind Pharm; 2010 Mar 19; 36(3):362-70. PubMed ID: 19719396 [Abstract] [Full Text] [Related] Page: [Next] [New Search]